Wallace Max N. has filed 7 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 80000 shares of Humacyte, Inc. ($HUMA) on June 12, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | Humacyte, Inc. | $HUMA | Wallace Max N. | Director | A | Stock Options (right to buy) | 80000 | $0.00 | 80,000.0000 | 155,118,816 | 9999.99% | 0.05% |
| June 13, 2024 | Humacyte, Inc. | $HUMA | Wallace Max N. | Director | A | Stock Options (right to buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| May 20, 2024 | Humacyte, Inc. | $HUMA | Wallace Max N. | Director | P | Common Stock | 4015 | $6.21 | 64,555.0000 | 0 | 6.63% | 0.00% |
| May 20, 2024 | Humacyte, Inc. | $HUMA | Wallace Max N. | Director | P | Common Stock | 3990 | $6.29 | 64,555.0000 | 0 | 6.59% | 0.00% |
| Nov. 21, 2023 | Humacyte, Inc. | $HUMA | Wallace Max N. | Director | M | Common Stock | 6564 | $1.19 | 56,550.0000 | 0 | 13.13% | 0.00% |
| Nov. 21, 2023 | Humacyte, Inc. | $HUMA | Wallace Max N. | Director | M | Stock Options (right to buy) | 6564 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 15, 2023 | Humacyte, Inc. | $HUMA | Wallace Max N. | Director | A | Stock Options (right to buy) | 8500 | $0.00 | 8,500.0000 | 0 | 9999.99% | 0.00% |